Sun, Dec 28, 2014, 6:28 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Microvision Inc. Message Board

videoctr 58 posts  |  Last Activity: Nov 17, 2014 8:12 PM Member since: Jun 28, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Immunotherapy for prostate cancer . . .

    by rehdvm2004 Nov 17, 2014 7:06 PM
    videoctr videoctr Nov 17, 2014 8:12 PM Flag

    I have worked with our urology department and have produced around 10 or more videos accepted by the AUA, on Extraperitoneal Radical Prostatectomy -- daVinci robotic surgeries, working with a world class surgeon and his Fellows. I still have a hard time though figuring out what I am looking at. Lol! I do know what anastomosis is and the importance of nerve sparing is. Lol. This would be the surgery of choice in my opinion given the various options that are available.

  • Reply to

    New Abstract

    by parabalic55 Nov 15, 2014 10:06 PM
    videoctr videoctr Nov 16, 2014 8:58 AM Flag

    Dr. Kim and team are adding value, big pharma please take notice. Thanks for posting this parabalic55. Seems like this is a counter measure to the cancer's counter measure.

    Inovio is an immuno-oncology vaccine and thereaputics company.

  • Reply to

    Short Interest decreased by 4.26 percent

    by videoctr Nov 15, 2014 6:10 PM
    videoctr videoctr Nov 15, 2014 6:58 PM Flag

    Perhaps that is a note worthy inflection point to remember, det.
    It's about time for the institutions to carpet bomb the shorts here.

  • Days To Cover (Short Interest Ratio)
    8.8

    Short Percent of Float
    20.79 %

    Short Interest - Prior
    12,297,100

    Short % Increase / Decrease
    -4.26

  • Reply to

    13F's? Any news today?

    by rollapair306 Nov 14, 2014 2:55 PM
    videoctr videoctr Nov 14, 2014 5:30 PM Flag

    Nice to see big money coming in, great validation. However, Inovio longs are smarter than the institutions. We were here first. Congrats.

    Naked short miscreant hedge funds, nasty bear raiding bloggers, and info-tainment pseudo financial mouth pieces, take note.

  • Reply to

    INO & Mad Money Tonight

    by veryinterestingbutstupid Nov 11, 2014 6:18 PM
    videoctr videoctr Nov 12, 2014 6:15 AM Flag

    Roche? DARPA, Medimmune?

  • Reply to

    INO & Mad Money Tonight

    by veryinterestingbutstupid Nov 11, 2014 6:18 PM
    videoctr videoctr Nov 12, 2014 4:34 AM Flag

    Why didn't Cramer like INO on the day Dr. Kim rang the bell on the NYSE? To be more accurate he should have said "the synthetic DNA market". We all know that human DNA can't be patented. So what does he mean when he says the, "DNA vaccine market"? What other company has what INO has?

    12 million shares are short.
    INO has a beta of 4, most likely due to the bear raids and short selling attacks and blog hit pieces, as well as stupid comments from TV financial info-tainment shows (Cramer - if the shoe fits?).

    The dwarfing has been attenuated by these miscreant short sellers, and yes, a government regulatory system that has made the market the most un-level, most gamed, market that is skewed against the retail investors like us.

  • videoctr videoctr Nov 9, 2014 8:54 AM Flag

    Inovio is taking steps to add value prior to future partnerships. Looking at the pipeline, they are doing just that. Tomorrow is an earnings date. I will anticipate just updates on earnings with perhaps some additional color on the studies we have/will have. It would be nice to have news of a partnership, icing on the cake. I am not feeling any partnership has to be announced by year end. Each study is a validation point of the science, which in time will make Inovio more valued by a potential suitor. Just my two cents.

  • Reply to

    Scientific American

    by videoctr Nov 8, 2014 7:19 PM
    videoctr videoctr Nov 9, 2014 6:00 AM Flag

    Scientific American, my comment;

    Inovio Pharmaceuticals will begin human phase 1 trials in a few months. Perhaps the author of this article can do a follow-up story on Inovio's approach using synthetic DNA based vaccines delivered by electroporation. In pre-clinical studies involving two animal models, they have demonstrated that their vaccine is 100 percent able to clear as well as to protect against Ebola. The purpose of which is to activate one's own immune system to fight the virus. The clear advantage of this platform is that it can scale to meet demand for manufacturing of the vaccine. The vaccine is made in pure water and does not have the concerns for temperature controls for shipping to tropical regions.

  • "Infection Secrets of Ebola Explained"
    By attacking the body's first responders, the virus cripples the immune system before it can mount an effective defense
    November 7, 2014 |By Helen Branswell

    (INO not mentioned)

  • videoctr videoctr Nov 6, 2014 6:33 AM Flag

    I read that bats are host adapted to more than 100 pathogens. Bats have a high metabolism being a flying mammal.

  • Reply to

    another day closer

    by bottom_thief Nov 6, 2014 5:34 AM
    videoctr videoctr Nov 6, 2014 6:02 AM Flag

    Another day closer to see chemotherapy and radiation therapy go away.

  • Reply to

    A thought about paradigm shifts in general

    by videoctr Nov 1, 2014 10:20 AM
    videoctr videoctr Nov 2, 2014 7:38 AM Flag

    puggy, I just saw your post. Agreed.

  • Reply to

    A thought about paradigm shifts in general

    by videoctr Nov 1, 2014 10:20 AM
    videoctr videoctr Nov 2, 2014 7:17 AM Flag

    Good thoughts whiskey.

    Paradigm shifts in general, I was thinking are not singular one person events. For instance I was thinking of BF Skinner who had the concept of teaching machines. He was ahead of his time, or I should say, he was ahead of the technology of the day, and had to work with analog based teaching "machines". He worked with what he had in his day. His learning theory and concepts however are a perfect fit for computers and online elearning we have today. So my point of "certain data points must be reached" should have been clarified better with this example. To sum up on paradigm shifts in general, they require external alignments and multi-discipline contributions, as you can see in my above example. The contributions by many add to a collective knowledge base to build ever better.

    On the subject of entrepreneurship,
    To advance the ball, sweat, genius, education are in the mix. I agree with your points.

    Yet there remains this point too. There is a depth to the human Spirit that can tap into something beyond the conscious self. For instance, Stephen Hawkings would see formulas in his dreams and he would advance mathematics from this "inner" connection. There is the non-local aspect science is acknowledging today, that is, the quantum level aspects of the world and the self are closely connected. For instance, a former remote viewer for the military, says, "Consciousness is only loosely connected to the physical body." He taught others to remote view as well. This paradigm shift shatters physical limitations. The military used this science when all other methods of reach were not possible. Interesting stuff.

    I am now going to work on zero point energy and anti-gravity. I'll be back soon.

  • A paradigm shift can be one that is a natural evolution which takes time to reveal itself fully, and is built upon a stream of data points along the way. No one can say with certainty, "I will get up today and change how this or that will get done. Need dictates action to solve something, need is the mother of invention, a great motivator that can provide inspiration to create. When a group such as a company of individuals work together to focus on a common problem the pace quickens toward resolution of the given objective.

    A major paradigm will be one where a lexicon of words will form, jargon, and a culture of sorts will include an ecosystem of new careers, new professional organizations, technology and support services. And there you have it, a new field of endeavor. Followed by educational institutions who will want to teach it and offer degrees to become specialists.

    How ironic is it for educational institutions to offer courses in "entrepreneurship"? How is vision taught? How is motivation taught to discover?

  • Reply to

    VP of Commercial Development

    by optimistyic321 Nov 1, 2014 9:43 AM
    videoctr videoctr Nov 1, 2014 9:53 AM Flag

    Dr. Kim wants to add value prior to partnering deal. Good luck longs.

  • Reply to

    Vaccines and Logistics in Africa

    by bullandbear1953 Oct 26, 2014 12:52 PM
    videoctr videoctr Oct 26, 2014 5:24 PM Flag

    This year 18 million dollars spent for the Obama's vacations. Just comparing and contrasting.

    News, "Tanzania, China sign East Africa investment deals worth $1.7 billion"

    it's about resources for China, natural gas deal. In return they are building a city. Winning hearts and minds or strategic planning? You decide.

    Future wars will be over resources.

  • videoctr videoctr Oct 26, 2014 10:29 AM Flag

    Nice find Bottom_Thief. This is also notable,

    "One vaccine in development is called BPSC-1001, the agency said. In previous studies, the vaccine has shown promise in animal testing, but it is made in lots of 1,000 to 5,000 vials. There may be risks, DTRA says, in producing larger amounts of the vaccine, which "requires a cold chain to maintain stability, which introduces complexity and risk into the use of this vaccine in austere conditions."

    The above statement shows that the competition cant scale and that a cold chain is required.

    I have another, "there I said it" comment. Is the military interest really humanitarian? Or is it part of a larger hegemony plan for the African continent? Ebola is a PR front for a globalist strategy. Okay, flame me now. Sorry, I question everything. Call me names, I can take it.

  • videoctr videoctr Oct 26, 2014 10:14 AM Flag

    In the recent Bloomberg video with Dr.Kim, he stated, "Inovio is a phase 3 oncology product company." I beleive that is the first time I have heard the company described that way.

    Inovio has fired the shot fired across the bow of the big pharma companies. It is also a ray of hope for the world to think that a vaccine/therapy is possible.

MVIS
1.83-0.02(-1.08%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST
PG&E Corporation
NYSEFri, Dec 26, 2014 4:02 PM EST